Author: Newsdesk

TORONTO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the month ending November 30, 2020, in respect of the Guardian Capital ETFs listed below. In each case, the distribution will be paid on November 30, 2020 to unitholders of record on November 24, 2020. The ex-dividend date in each case is November 23, 2020.  

Exchange Traded Fund	Class of Units	Distribution Frequency	Trading Symbol	Distribution Amount (per Unit)
Guardian Directed Equity Path ETF	Hedged	Monthly	GDEP	$0.0667
Guardian Directed Equity Path ETF	Unhedged	Monthly	GDEP.B	$0.0667
Guardian Directed Premium Yield ETF	Hedged	Monthly	GDPY	$0.10
Guardian Directed Premium Yield ETF	Unhedged	Monthly	GDPY.B	$0.10

About Guardian Capital LP

Guardian Capital LP is the manager and portfolio manager of the Guardian Capital Funds and each of the Guardian ETFs. Additionally, Guardian Capital manages portfolios for defined benefit and defined contribution pension plans, insurance companies, foundations, endowments and third-party mutual funds. Guardian Capital is a wholly-owned subsidiary of Guardian Capital Group Limited. For further information on Guardian Capital, please visit www.guardiancapitallp.com.

About Guardian Capital Group Limited

Guardian Capital Group Limited is a diversified financial services company founded in 1962. Guardian operates in two main business areas, Asset Management and Financial Advisory. As of September 30, 2020, Guardian had C$32.7 billion of assets under management and C$20.8 billion of assets under administration. Guardian offers institutional and private wealth investment management services; financial services to international investors; services to financial advisors in its national mutual fund dealer, securities dealer, and insurance distribution network; and maintains and manages a proprietary investment portfolio, which had a fair market value of C$552 million at September 30, 2020. Its Common and Class A shares are listed on the Toronto Stock Exchange; in 2019, Guardian celebrated 50 years as a listed company. To learn more about Guardian, visit www.guardiancapital.com.

For further information, please contact Guardian Capital at 416-350-8899 or visit www.guardiancapital.com.

This communication is intended for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase Guardian Capital ETFs and is not, and should not be construed as, investment, tax, legal or accounting advice, and should not be relied upon in that regard. Commissions, management fees and expenses all may be associated with investments in exchange-traded funds (ETFs). Please read the prospectus before investing. ETFs are not guaranteed, their values change frequently and past performance may not be repeated. You will usually pay brokerage fees to your dealer if you purchase or sell units of an ETF on the TSX. If the units are purchased or sold on the TSX, investors may pay more than the current net asset value when buying units of the ETF and may receive less than the current net asset value when selling them.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — GSP Resource Corp. (TSX-V: GSPR) (the “Company” or “GSP”) is pleased to announce that it has closed a non-brokered private placement of 1,375,000 units (each, a “Unit”) at a price of $0.40 per Unit for gross proceeds of $550,000 (the “Private Placement”). Each Unit consists of one ‘flow-through’ common share and one-half of one transferable common share purchase warrant (“Warrants”). Each whole Warrant entitles the holder to purchase one common share of the Company at a price of $0.50 per share for a period of two (2) years following the date of issuance.

In connection with the closing of the Private Placement, the Company paid aggregate cash finder’s fees of $29,750 and issued 96,250 non-transferable finder warrants to certain brokers, having the same terms as the Warrants.

All securities issued pursuant to the Private Placement are subject to a four-month hold period from the closing date in accordance with applicable securities laws.

Proceeds from the Private Placement are expected to be used for exploration work on the Company’s projects.

About GSP Resource Corp.: GSP Resource Corp. is a mineral exploration & development company focused on projects located in Southwestern British Columbia. The Company has an option to acquire a 100% interest and title to the Alwin Mine Copper-Gold-Silver Property in the Kamloops Mining Division, as well as an option to acquire 100% interest and title to the Olivine Mountain Property in the Similkameen Mining Division.

Contact Information – For more information, please contact:
Simon Dyakowski, Chief Executive Officer & Director
Tel: (604) 619-7469
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

Forward-Looking Information

This news release contains “forward‐looking information or statements” within the meaning of applicable securities laws, which may include, without limitation, use of funds from the Private Placement, future exploration work on the Company’s projects, and other matters. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Such statements and information are based on numerous assumptions regarding present and future business strategies, including the price of metals, the ability to achieve its goals, and that general business and economic conditions will not change in a material adverse manner. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including those filed under the Company’s profile on SEDAR at www.sedar.com. Factors that could cause actual results to differ materially from those in forward looking statements include, but are not limited to, continued availability of capital and financing and general economic, market or business conditions, failure to maintain all necessary government permits, equipment failures, adverse weather conditions, the impact of Covid-19 or other viruses and diseases on the Company’s ability to operate, approvals and authorizations, and failure to maintain community acceptance (including First Nations). The Company does not undertake to update forward‐looking statements or forward‐looking information, except as required by law.

• Revenues grow 64.8% over the immediately preceding quarter
  and a 115.3% increase over the corresponding period of the prior year
• Loss per share of 8.5 cents in line with levels of immediately preceding quarter

REDWOOD CITY, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, reported results for the three months ended September 30, 2020. During the three months ended September 30, 2020, the Company earned device sales and technology fees totaling $744,585. Expansive growth into new clinics adopting Bioflux resulted in September being the Company’s highest revenue-producing month to date. Full results are available on EDGAR or in the Financial Section of the Company’s website.

“During the six months ended September 30, 2020, the Company earned revenues of $1,196,483 compared to $672,906 in the corresponding prior year period – a 77.8% increase,” stated Waqaas Al-Siddiq, CEO of Biotricity.

“During the three and six months ended September 30, 2020, the Company experienced a gross margin of 43.6% and 48.9%, respectively.” Biotricity’s CFO, John Ayanoglou added, “Management expects that the cost of devices sold, and other technology associated fees will become lower as a percentage of revenues as sales volumes expand.  For the quarter ended September 30, 2020, Biotricity incurred a net loss of 0.085 cents per share, which was in line with the net loss per share of 0.090 posted in the immediately preceding quarter.”  

During our initial commercialization of the Bioflux and the build-out of the Company’s expanded technology eco-system, we devoted significant resources to hiring a high-caliber sales force and our research and development programs incurring additional operating losses.  As we continue to build the infrastructure required to increase sales volumes rapidly, we expect these operating losses will continue.

Dr. Waqaas Al-Siddiq noted, “We provide our clinical customers and the patients they serve with potentially lifesaving remote medical monitoring. Our goal is to continue to expand our market penetration and product offering as we establish our vision of providing the patients our technology serves with a superior continuum of care.”

Alongside sales growth, the Company has focused on the continued enhancement of its core technology and R&D efforts, leading to several key milestones in recent months that include the following:

1. FDA Clearance of the Bioflux II software
2. Launched Biocare Telemed, a telemedicine platform to support remote prescriptions and follow up visits
3. Launched Biocare Direct, a program that supports physicians and at-risk patients by shipping Bioflux directly to the patients’ home when prescribed by a physician
4. Verizon Partnership to develop EMS solutions

Biotricity management will host a conference call and live webcast for analysts and investors on November 19, 2020 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the company’s financial results for the quarter.

To access the live call, dial 323-289-6576 (local) or 800-437-2398 (toll free) and give the participant passcode 9877135.

A live and archived webcast of the conference call will be accessible on the Investor Relations section of the company’s website at www.biotricity.com. In addition, a phone replay will be available approximately two hours following the end of the call, and will remain available for one week. To access the call replay, please use the following link.

Registration for Call-in Audio Replay
Web Address URL:  Click Here

Call-in Audio Replay Passcode:   9877135

About Biotricity Inc. 
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity’s unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.

Important Cautions Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “will,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of Bioflux or any of the Company’s other proposed products or services, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company’s future financial performance, (iv) the regulatory regime in which the Company operates or intends to operate and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company’s inability to obtain additional financing, the significant length of time and resources associated with the development of its products and related insufficient cash flows and resulting illiquidity, the Company’s inability to expand the Company’s business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. These and other factors are identified and described in more detail in the Company’s filings with the SEC. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Donna Loughlin Michaels LMGPR 408.393.5575 [email protected]

Biotricity Inc. 1-800-590-4155 [email protected]

NEWPORT BEACH, Calif. and SALT LAKE CITY, Nov. 17, 2020 (GLOBE NEWSWIRE) — VERB Technology Company, Inc.(NASDAQ: VERB) (“VERB” or the “Company”), a leader in interactive video-based sales enablement applications, including interactive livestream ecommerce, webinar, CRM and marketing applications for entrepreneurs and enterprises, today announced that Shaklee Corporation (“Shaklee”), a leading global provider of natural nutrition, personal care and environmentally friendly home care products, has adopted verbCRM, VERB’s interactive video-based customer relationship management and sales enablement platform, and verbLEARN, VERB’s interactive video-based learning management system, for use in direct selling by and training of its global network of distributors. Shaklee launched the VERB apps at its first-ever virtual conference in September 2020. The apps have been deployed in the U.S. and Canada.

With more than 1.2 million members and distributors in the U.S., Japan, Mexico, Malaysia, Canada, Taiwan, and China, Shaklee is one of the largest direct sales companies in the world and a leading natural nutrition and green cleaning products company in the U.S. It was the first company in the world to become Climate Neutral Certified in the year 2000 and is a fully carbon neutral organization.

verbCRM will be used as a selling resource by Shaklee’s distributors in marketing its products, acquiring new customers, and solidifying existing customer relationships. It allows Shaklee users to easily engage with customers by easily sharing product information, video content and promotions directly with their customers and through social media, transforming the direct selling process into an interactive experience that allows them to monitor and act upon customer engagement. The app includes verbCRM’s sampling feature that allows users to manage and send sample products to potential and existing customers. verbLEARN will be used in training and onboarding, as well as retention, of Shaklee’s distributors. Implementation is expected to be efficient as the VERB platform is fully integrated with Salesforce, Shaklee’s enterprise software.

“We’re proud to add Shaklee to our expanding client base for verbCRM and verbLEARN,” stated Rory J. Cutaia, CEO of VERB. “We believe our sales enablement tools will further enhance Shaklee’s global leadership position as a direct seller of popular nutrition, wellness and green cleaning products by empowering its large distributor base.

“We’re also excited that Shaklee has been among the first large enterprises to subscribe for our new Salesforce synch feature we developed for our verbCRM platform. We hope to add Shaklee to our growing list of subscribers for verbLIVE, our interactive video-based livestream ecommerce and webinar product, for their distributors, whom we believe will benefit from our video-based sales technology and accompanying viewer engagement analytics. Adoption and deployment of verbLIVE will be quick and easy especially since they are already on the verbCRM platform.”

Roger Barnett, Shaklee Chairman and CEO, said, “We are focused on continually supporting our global distributors by providing them the best modern, digital tools available, and we are delighted to launch verbCRM and verbLEARN via our Shaklee Share App, which we believe will make the selling and training process more efficient. Direct selling is one of the most proven and time-tested ways for people to earn supplemental income, and today it is increasingly possible to do so in a digital and flexible way.”

About Shaklee

Shaklee is a leading natural nutrition company founded by Dr. Shaklee who invented the multi-vitamin in the US over 100 years ago. A pioneer in sustainability, Shaklee was the first company in the world to fully offset its carbon emissions so as to leave no footprint on our planet. Shaklee products are backed by over 100 published clinical studies proving safety and efficacy and are marketed through more than 2 million members and distributors in North America and Asia.

About VERB

VERB Technology Company, Inc. (Nasdaq: VERB) transforms how businesses attract and engage customers. The Company’s Software-as-a-Service, or SaaS, platform is based on its proprietary interactive video technology, and comprises a suite of sales enablement business software products offered on a subscription basis. Its software applications are available in over 60 countries and in more than 48 languages to large enterprise and small business sales teams that need affordable, easy-to-use, and quick-to-get-results sales tools. Available in both mobile and desktop versions, the applications are offered as a fully integrated suite, as well as on a standalone basis, and include verbCRM (Customer Relationship Management application), verbLEARN (Learning Management System application), and verbLIVE (Interactive Livestream eCommerce and Video Webinar application). The Company has offices in California and Utah. For more information, please visit: www.verb.tech.

FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements that involve risks and uncertainties, including statements about the closing of the offering of common stock. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of our assumptions prove incorrect, our actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include risks associated with: the COVID-19 pandemic and related public health measures on our business, customers, markets and the worldwide economy; our plans to attract new customers, retain existing customers and increase our annual revenue; the development and delivery of new products, including verbLIVE; our plans and expectations regarding software-as-a-service offerings; our ability to execute on, integrate, and realize the benefits of any acquisitions; fluctuations in our quarterly results of operations and other operating measures; increasing competition; general economic, market and business conditions; and the risks described in the filings that we make with the Securities and Exchange Commission (“SEC”) from time to time, including the risks described under the headings “Risk Factors” and “Management Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K, which was filed with the SEC on May 14, 2020, as amended by Amendment No. 1 on Form 10-K/A to our Annual Report on Form 10-K, which was filed with the SEC on June 4, 2020, and which should be read in conjunction with our financial results and forward-looking statements contained therein, and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, which was filed with the SEC on November 16, 2020, which should be read in conjunction with our financial results and forward-looking statements contained therein. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Investor Relations Contact:

888.504.9929
[email protected]

Media Contact:
855.250.2300, ext.107
[email protected]

SAN JOSE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — NeuVector, the leader in Full Lifecycle Container Security, today announced that customers switching to NeuVector receive a 30% discount off the fees paid for their current container security platform. The announcement is being made at KubeCon and CloudNativeCon 2020, where NeuVector is a Silver Sponsor.

New customers interested in taking advantage of the promotion can stop by the NeuVector booth in the Silver exhibit hall at KubeCon or reach out to [email protected] for more information, to begin their proof-of-concept, and to clearly understand NeuVector’s competitive advantages. New customers completing a qualified POC and purchasing the NeuVector solution save 30% off the cost of their existing solution. They will also receive their choice of a welcome gift (including a drone, iPad, or a donation to a selected charity). The promotion will run through December 31, 2020.

NeuVector enables enterprises to secure container and Kubernetes environments throughout the entire application lifecycle. NeuVector’s patented container firewall technology delivers the defense-in-depth capabilities to defeat even zero-day attacks and threats with unknown origin. Through behavioral learning, Security-as-Code, and automation processes throughout the CI/CD pipeline and at run-time, security vulnerabilities and abnormal behavior are detected – enabling DevOps and DevSecOps teams to neutralize threats. NeuVector is continually adding new capabilities that expand and harden its solution, such as compliance templates and serverless security.

“We believe our new promotion for KubeCon and CloudNativeCon will make it an even easier choice to leverage NeuVector for end-to-end container security,” said Stephanie Fohn, CEO, NeuVector. “We continue to see an influx of organizations migrating to NeuVector from other solutions that lack comprehensive feature-sets, are challenging for DevOps and DevSecOps teams to operate, cannot block zero-day threats, or are not easily integrated with popular orchestration tools. With this promotion, we want to raise the incentives to make it a no-brainer to see how NeuVector can address container security challenges with unmatched run-time security, developer-friendly security automation, and simplified operations.”

About NeuVector

NeuVector, the leader in Full Lifecycle Container Security, delivers uncompromising end-to-end security for modern container infrastructures. NeuVector offers a cloud-native Kubernetes security platform with end-to-end vulnerability management, automated CI/CD pipeline security, and complete run-time security – including the industry’s only container firewall to block zero-day attacks and other threats. NeuVector customers include global leaders in financial services, healthcare, transportation, government and other industries. For customers in highly regulated industries, NeuVector simplifies compliance for PCI, GDPR, HIPAA, and other stringent data security mandates. NeuVector integrates with leading cloud platforms, CI/CD tools, and monitoring tools. Founded by industry veterans from Fortinet, VMware, and Trend Micro, NeuVector has developed patented behavioral learning for container security.

Contact
Kyle Peterson
[email protected]

SCOTTSDALE, Ariz., Nov. 17, 2020 (GLOBE NEWSWIRE) — Meritage Homes, the seventh-largest homebuilder in the U.S., today announced an industry-first expansion to its healthy home construction offerings. Meritage Homes has already begun installing MERV-13 filters standard in all its new homes. With its 100% clean air quality commitment, the company will now carry the Environmental Protection Agency’s (EPA) Indoor airPLUS certification, a labeling program aimed at improving indoor air in new homes by requiring construction and product specifications that reduce exposure to airborne containments. For 35 years, Meritage Homes has built homes with a focus on creating a better living environment for its residents and has been recognized as an EPA ENERGY STAR® Partner of the Year from 2013 to 2019. Additionally, the company utilizes healthier building -components such as low VOC paints/stains, spray foam insulation and sealed insulated ducts to help homeowners live healthier lives. This new standard and certification underscore the company’s ongoing commitment to driving innovation in new home construction, while continuing to focus on the health and safety of its customers.

Unlike conventional filters, the MERV-13 filter is designed to remove smaller particles which can reduce or eliminate a variety of air allergens including dust, lint, pollen, mold and even some bacteria and viruses. The MERV-13 filter is one of the highest filtration standards available for today’s HVAC systems. This new standard joins Meritage Homes’ existing commitment to its homeowners, who have the comfort in knowing that their home affords them:

• Real
  Comfort—Low-E windows block UV rays, help keep indoor temperatures consistent and remove undue strain on HVAC systems
• Better Health—Spray foam insulation is the first line of defense for the home. It keeps pests and pollutants out while helping to reduce home air loss. In addition, the advanced ventilation system brings in clean, fresh air; promoting a healthy air exchange within the home
• More Savings—ENERGY STAR® certified appliances and water-saving technology run more efficiently and reduce utility bills by more than 50 percent
• Peace of Mind—With a proven track record of success, the M.Connected Home Automation Suite of smart home features and higher building standards, residents can worry less and enjoy their home more

“We are extremely proud to be the first public builder to bring the MERV-13 air filtration standard and the EPA airPLUS certification to all of our buyers. Over the last decade, Meritage Homes has set the standard for energy-efficient home building and demonstrated a deep commitment to welcoming families into a new home that supports better health,” said Steve Hilton, CEO of Meritage Homes.

Phillippe Lord, COO of Meritage Homes adds, “Given today’s environment, we understand that our consumers are looking for ways to keep their homes safer and healthier. The adoption of the latest in air filtration technology enables Meritage Homes to meet and exceed buyers’ expectations and deliver on our promise to set new building standards and raise the bar across the industry.”  

The upgraded MERV-13 filtration system and Indoor airPLUS certification, coupled with healthy building practices that reduce chemicals used in the home, allows homeowners to create an even better living environment for their families. 

For more information on Meritage Homes’ healthy home offerings, please visit: https://www.meritagehomes.com/why-meritage/energy-efficiency

About Meritage Homes

Meritage Homes is the seventh-largest public homebuilder in the United States, based on homes closed in 2019. Meritage Homes offers a variety of homes that are designed with a focus on first-time and first move-up buyers in Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina and Tennessee.

The Company has designed and built over 135,000 homes in its 35-year history, and has a reputation for its distinctive style, quality construction, and award-winning customer experience. Meritage Homes is the industry leader in energy-efficient homebuilding and a seven-year recipient of the U.S. Environmental Protection Agency’s ENERGY STAR® Partner of the Year for Sustained Excellence Award since 2013 for innovation and industry leadership in energy efficient homebuilding.

For more information, visit www.meritagehomes.com.

Contacts:		Emily Tadano, VP Investor Relations
		(480) 515-8979 (office)
		[email protected]

PETERBOROUGH, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) — Electronics repair shop uBreakiFix is now open in Peterborough at 550 Lansdowne St. W. The store offers repairs on smartphones, tablets, computers, and more to help the community stay connected.

uBreakiFix Peterborough is owned by Zain Jaffery and Sabil Ur-Rehman. The business partners have hopes to expand by opening more uBreakiFix locations in the surrounding areas in the future.

“Staying connected is critical right now and it’s rewarding to be part of something that makes that possible for those in our community,” said Jaffery. “Prior to opening our uBreakiFix in Peterborough, we owned a private cell phone repair business. This opportunity has allowed us to not only expand our services but also reach more customers who can benefit from what we have to offer.”

uBreakiFix offers repair service on anything with a power button, from smartphones, tablets, and computers to drones, hoverboards, and game consoles. To date, uBreakiFix has completed more than 9 million repairs at its more than 600 locations across North America. While common fixes include shattered screens, software, and camera issues, the brand offers support for most technical problems on any electronic device, regardless of make or model.

“At uBreakiFix, our goal is to provide genuine, authorized repairs and solutions to our customers,” Jaffery said. “We want to be the go-to technology repair solution that offers convenience and accessibility to the community we serve. This year has provided a number of challenges but we believe a broken phone, tablet, or computer shouldn’t be one of them.”

uBreakiFix was founded in 2009 by millennial entrepreneurs Justin Wetherill and David Reiff to fill a gap in the market for affordable, high-quality phone repair. The duo soon partnered with Eddie Trujillo to transition their Internet-based repair brand to a brick-and-mortar model. uBreakiFix began franchising in 2013 and currently operates more than 600 locations across the U.S. and Canada.

“At uBreakiFix, our story has been shaped by an unwavering commitment to continually improving the repair experience for customers,” Wetherill said. “We founded this company to fill a need for high-quality, convenient repair with great service at a fair price. We always say we’re a customer service company first, and a tech company second. As we begin serving Peterborough and the surrounding communities, we look forward to sharing the care and credibility that define the uBreakiFix experience.”

For more information and to view a service menu, visit ubreakifix.com/locations/peterborough. uBreakiFix Peterborough is located at:

uBreakiFix

550 Lansdowne St W, Peterborough, ON K9J 8J8, Canada

+1 70
5-745-9565

About uBreakiFix


Founded in 2009, uBreakiFix specializes in the repair of small electronics, ranging from smartphones, game consoles, tablets, computers, and everything in between. Cracked screens, software issues, camera issues, and most other problems can be repaired by visiting uBreakiFix stores across the U.S. and Canada. Since 2016, uBreakiFix has served as the exclusive walk-in repair partner for Google Pixel customers. In 2018, uBreakiFix became a Samsung Care authorized service provider offering same-day, in-person support for Samsung Galaxy customers across the U.S. In 2019, uBreakiFix joined the Asurion family and now operates as a subsidiary of the tech care company while still maintaining the uBreakiFix leadership team and franchise model. For more information, visit

ubreakifix.com

.

For more information, contact:

Ellie Holt
(229) 869-5305
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8daabaf8-5b16-4ad7-a5e5-1f8ae6af79fc

 

CHARLOTTETOWN, Prince Edward Island, Nov. 17, 2020 (GLOBE NEWSWIRE) — The deployment of Rendever’s virtual reality (VR) platform in hospitals and public long-term care nursing facilities at Health PEI, the single health authority for the Canadian province of Prince Edward Island, is connecting patients and residents with far-away places and their favourite locations, all from the comfort and safety of their own rooms.

Health PEI is the first government agency to bring Rendever’s technology to residents. Rendever, a company that offers a VR platform specifically designed for older adults, opens up a world of possibilities for patients and senior living residents. Through this innovative use of VR, users can travel around the globe, check off bucket list items, connect with others, and engage with the world in ways that were not possible before.

Within the first three months of deployment, staff hosted more than 60 Rendever VR sessions. In total, the team delivered 2,400 experiences and participants spent 59 hours in VR (equivalent to nearly two-and-a-half days).

Rendever’s VR platform has proven to be one of the most helpful tools throughout the COVID-19 pandemic and exceeded all expectations during this time of crisis. In fact, the Health PEI team was so active and consistent in their use of the Rendever systems that they were selected to beta test a brand new interactive application designed specifically in response to the coronavirus – The Connection Corner.

“The heightened safety protocols to protect our patients and residents from COVID-19 have been paramount, but the isolation and loneliness that comes with quarantine is significant,” said Paul Young, Administrator for Community Hospitals West. “Rendever has been a bright spot for our residents and patients – both before and during this global pandemic. While many of our peers in the industry had the knee jerk reaction to halt all group activities, our team used innovation and technology to pivot the delivery of our activities, while still offering amazing engagement opportunities. We are extremely proud of this.”

McKnight’s Long-Term Care News, the pre-eminent national media brand for senior living, recently awarded Health PEI with the bronze prize for the Innovator of the Year category of their 2020 McKnight’s Excellence in Technology Awards.

Health PEI is the latest to join more than 200 senior living and care organizations across North America and Australia using Rendever.

“We are absolutely delighted to work with Health PEI to bring joy and engagement to patients and senior living residents across Prince Edward Island,” said Kyle Rand, Cofounder and CEO of Rendever. “Empowering people to reminisce, share memories, find common ground, and ultimately build meaningful relationships with one another is something that will never get old, and is important now more than ever.”

For more details on Rendever, visit www.rendever.com. Click here for more details on Health PEI.

About
Rendever

Rendever is overcoming social isolation through the power of virtual reality and shared experiences. From senior living communities to hospitals, their platform is being used to reduce depression and loneliness by fostering personal connections amongst populations where life has become limited. Participants in group sessions can check off bucket list items together, revisit meaningful places and share stories, stay engaged with family members, and more. Rendever is being used by high-profile senior living operators including Revera, Benchmark, and SRG, healthcare systems such as UCHealth and Cleveland Clinic, has research funded by the NIH and NIA, and has commercial partnerships with major organizations like AARP and Verizon. To learn more, please visit www.rendever.com.

About Health PEI

Health PEI is responsible for the delivery of publicly funded health services in Prince Edward Island. The organization operates hospitals, health centres, public long-term care nursing facilities and community-based programs and services.

Health PEI’s primary goals are to:

• provide Islanders with safe, quality, person-centered care and services;
• provide access to appropriate care by the right provider in the right setting; and
• optimize resources and processes to sustain a viable health care system.

Media Contact

Elsa Anschuetz
Uproar PR for Rendever
321-236-0102 x233
[email protected] 

EMERYVILLE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — National Mortgage Insurance Corporation (National MI), the primary operating subsidiary of NMI Holdings, Inc. (NASDAQ: NMIH), is now integrated with Loan Originator Networks,LLC (LON), which creates websites for mortgage lenders and integrates seamlessly with their loan origination systems (LOS). LON worked with National MI to offer a new functionality that provides National MI’s risk-based pricing engine, RateGPS®, in LONPricer, a comprehensive platform that handles all mortgage channels—retail, wholesale, correspondent, and consumer direct.

The integration brings National MI’s innovative, real-time, risk-based mortgage insurance pricing to LONPricer. “National MI is delighted to join forces with LON,” said Norm Fitzgerald, chief sales officer with National MI. “Having access to our Rate GPS risk-based pricing through the LON platform will save lenders time and streamline the origination process.”

LON is uniquely set up to capture the growing wholesale market by providing wholesale lenders and brokers with the ability to transact in a very efficient and transparent way. “National MI is focused on strengthening its engagement with all originators, including brokers and wholesale lenders, and this integration will help further our efforts,” Fitzgerald added.

“We’re very pleased to provide lenders with access to National MI’s RateGPS pricing through LONPricer,” said Michael Baker, senior vice president, product development and distribution with LON. “This integration supports loan officers by providing borrowers with accurate risk-based MI pricing at the point of sale. The LON platform is capable of overwriting terms and pricing, which supports the loan officer’s ability to ‘self disclose’ without a manual review or set up process. We chose National MI because of their expertise in integrations and advanced APIs.”

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements about future, not past, events and involve certain important risks and uncertainties, any of which could cause our actual results to differ materially from those expressed in our forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding the performance of National MI’s technology integration. Any or all of our forward-looking statements in this press release may turn out to be inaccurate. More information about the risks, uncertainties and assumptions affecting National MI can be found in the risk factors and forward-looking statements cautionary language contained in our Annual Report on Form 10-K and in other filings made with the Securities and Exchange Commission. We have based these forward-looking statements on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, operating results, business strategy and financial needs. All forward-looking statements are necessarily only estimates of future results, and actual results may differ materially from expectations. You are, therefore, cautioned not to place undue reliance on such statements. We do not undertake, and specifically disclaim, any obligation to revise any forward-looking statements to reflect the occurrence of future events or circumstances.

About National MI

National Mortgage Insurance Corporation (National MI), a subsidiary of NMI Holdings, Inc. (NASDAQ: NMIH), is a U.S.-based, private mortgage insurance company enabling low down payment borrowers to realize home ownership while protecting lenders and investors against losses related to a borrower’s default. To learn more, please visit www.nationalmi.com.

About
Loan Originator Networks, LLC

LON, based in Woodinville, WA., was established in 2000 by Gordon Shaw, Chief Engineer and Founder. LON is a full service Web Portal Development firm that supports a “Single Branded Solution” for Third Party Aggregators and Retail Originators. LON supports Banks and Non-Banks with a reg Z business decisioning price engine, LONPricer. LON customers are able to support a custom file flow by leveraging the client’s existing Document and Database of Record and all of the latest industry-leading API integrations. LON is currently accepting RFP’s for First and Second Quarter, 2021 delivery. Learn more: www.loanoriginator.com or contact: [email protected]

Press Contact for National MI

Mary McGarity
Strategic Vantage Mortgage Public Relations
(203)260-5476
[email protected]

Investor Contact for National MI

John M. Swenson
Vice President, Investor Relations and Treasury
[email protected]
(510)788-8417 

ROSELAND, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter and nine months ending September 30, 2020.

Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, commented, “This quarter, our dental business improved considerably as dental offices began to reopen across the country and around the world. Specifically, our dental sales increased more than seven-fold versus the second quarter of 2020. Importantly, our marketing initiatives and ‘back to work’ promotions have been well received, as we are working hard to address the needs of both dentists and their patients during the pandemic.”

“With a number of hospitals re-opening to outside vendors, we are advancing our sales efforts and exploring new collaboration opportunities around the CompuFlo® Epidural System and CathCheck™. Most recently, we were awarded a group purchasing agreement with Premier, a leading group purchasing organization, with approximately 4,100 U.S. hospitals and 200,000 other providers within their network. This agreement is further validation of the growing awareness and importance of our instruments in improving health outcomes and lowering costs for healthcare institutions. At the same time, we are expanding our trials in major hospitals and medical schools, as well as partnering with key opinion leaders to approach the purchasing departments of hospitals together. We look forward to announcing additional agreements with several premier hospitals as soon as they are completed. Finally, we have a strong cash runway with over $14 million of cash on hand as of September 30, 2020. This liquidity, combined with our improved cash flow, will support our ongoing activities, including accelerated marketing activities around both our dental and medical instruments.”

For the three months ended September 30, 2020 and 2019, revenues were approximately $1.2 million and $1.9 million, respectively. Dental revenues decreased by approximately $644,000, due to the impact of the COVID-19 pandemic on the Company’s customers, suppliers, vendors, and other business partners. Gross profit for the third quarter ended September 30, 2020 was approximately $836,000, or 67% of revenue, versus approximately $1.4 million, or 72% of revenue for the third quarter ended September 30, 2019. Operating loss for the three months ended September 30, 2020 was approximately $(1.5) million versus $(1.0) million for the three months ending September 30, 2019. The increase in operating loss is due to decreased dental revenue. Net loss for the three months ended September 30, 2020 was approximately $(1.5) million, or $(0.02) per share, versus a net loss $(2.8) million, or $(0.06) per share, in the prior period.

For the nine months ended September 30, 2020 and 2019, revenues were approximately $3.2 million and $6.1 million, respectively. Dental revenues decreased by approximately $2.8 million, which is related to decrease in sales of handpieces and devices throughout the country and internationally due to the COVID-19 pandemic. Gross profit for the nine months of 2020 was $2.2 million or 68% of revenue versus $4.2 million or 69% of revenue for the first nine months of 2019. Operating loss for the nine months of 2020 was approximately $(6.3) million versus approximately $(2.9) million for the nine months of 2019. Net loss for the nine months of 2020 was $(6.3) million, or $(0.11) per share, versus net loss of $(4.7) million, or $(0.11) per share, for the comparable period in 2019.

Conference Call

Milestone Scientific’s executive management team will host a conference call at 8:30 AM Eastern Time Tuesday, November 17, 2020 to discuss the Company’s financial results for the third quarter ended September 30, 2020, as well as the Company’s corporate progress and other developments.

The conference call will be available on the Company’s website at www.milestonescientific.com, or via telephone by dialing toll free 877-407-0778 for U.S. callers, or +1 201-689-8565 for international callers. For those unable to participate at that time, a replay of the call will be archived on the company’s website or can be accessed by dialing 877-481-4010 for U.S. callers, or +1 919-882-2331 for international callers and entering the pass code 38544. The replay will be available for 90 days.

About Milestone Scientific Inc.


Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone’s ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in
our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report for the year ended December 31, 201
8
. The forward
–
looking statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
		September 30, 2020				December 31, 2019
ASSETS
Current assets:
Cash and cash equivalents		$	14,448,903			$	1,516,272
Accounts receivable, net			962,983				1,710,665
Prepaid expenses and other current assets			527,059				519,063
Inventories, net			2,229,760				1,620,509
Advances on contracts			723,084				710,662
Total current assets			18,891,789				6,077,171
Furniture, fixtures and equipment, net			31,311				44,976
Patents, net			342,501				382,260
Right of use assets			655,870				15,977
Other assets			24,150				35,905
Total assets		$	19,945,621			$	6,556,289
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	666,094				1,379,425
Accounts payable, related party			393,090				1,358,752
Accrued expenses and other payables			1,147,698				775,055
Accrued expenses, related party			593,625				1,057,958
Current portion of finance leases			7,903				3,904
Current operating lease right-of-use liabilities			68,934				12,072
Note payable			276,180				–
Deferred profit, related party			340,476				340,476
Total current liabilities			3,494,000				4,927,642
Finance lease liabilities, non-current			30,624				–
Operating lease right-of-use liabilities			576,407				–
Total liabilities		$	4,101,031			$	4,927,642
Commitments and contingencies
Stockholders’ equity
Common stock, par value $.001; authorized 75,000,000 shares; 63,605,119 shares issued and 63,571,786 shares outstanding as of September 30, 2020; 49,410,176 shares issued and 49,376,843 shares outstanding as of December 31, 2019;			63,605				49,410
Additional paid in capital			116,577,241				96,082,324
Accumulated deficit			(99,806,352	)			(93,524,297	)
Treasury stock, at cost, 33,333 shares			(911,516	)			(911,516	)
Total Milestone Scientific Inc. stockholders’ equity			15,922,978				1,695,921
Noncontrolling interest			(78,388	)			(67,274	)
Total stockholders’ equity			15,844,590				1,628,647
Total liabilities and stockholders’ equity		$	19,945,621			$	6,556,289

MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
	Three months ended September 30, 2020				Three months ended September 30, 2019				Nine months ended September 30, 2020				Nine months ended September 30, 2019
Product sales, net	$	1,246,110			$	1,899,821			$	3,225,170			$	6,073,580
Cost of products sold		409,621				523,672				1,024,947				1,894,550
Gross profit		836,489				1,376,149				2,200,223				4,179,030
Selling, general and administrative expenses		2,291,779				2,314,943				8,221,359				6,941,964
Research and development expenses		21,438				7,940				237,089				109,815
Total operating expenses		2,313,217				2,322,883				8,458,448				7,051,779
Loss from operations		(1,476,728	)			(946,734	)			(6,258,225	)			(2,872,749	)
Interest expense		(569	)			(2,449	)			(8,727	)			(6,067	)
Change in fair value of derivative liability		–				(1,899,484	)			–				(1,846,761	)
Loss before provision for income taxes and net of equity investments		(1,477,297	)			(2,848,667	)			(6,266,952	)			(4,725,577	)
Provision for income taxes		(24,717	)			(1,250	)			(26,217	)			(19,877	)
Loss before equity in net earnings (losses) of equity investments		(1,502,014	)			(2,849,917	)			(6,293,169	)			(4,745,454	)
Earnings from China Joint Venture		–				–				–				49,099
Net loss		(1,502,014	)			(2,849,917	)			(6,293,169	)			(4,696,355	)
Net loss attributable to noncontrolling interests		11,025				12,941				35,501				35,343
Net loss attributable to Milestone Scientific Inc.	$	(1,490,989	)		$	(2,836,976	)		$	(6,257,668	)		$	(4,661,012	)
Net loss per share applicable to common stockholders–
Basic		(0.02	)			(0.06	)			(0.11	)			(0.11	)
Diluted		(0.02	)			(0.06	)			(0.11	)			(0.11	)
Weighted average shares outstanding and to be issued–
Basic		65,817,132				47,721,732				56,478,151				43,311,984
Diluted		65,817,132				47,721,732				56,478,151				43,311,984

Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: [email protected] 
Tel: 212-671-1020